NDC codes

FDA NDC Directory
Product NDC (as listed)60505-4552Labeler and product segments. Claims need a package NDC.
Product NDC at billing width60505-4552Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
60505-4552-36050545520330 TABLET, FILM COATED in 1 BOTTLE (60505-4552-3)Marketed from Sep 19, 2022

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Ambrisentan
Generic name (nonproprietary)
ambrisentan
Active ingredients
Ambrisentan — 5 mg/1
Dosage form
Tablet, Film coated
Route
Oral
Labeler
Apotex Corp.NDC labeler code 60505
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 210701
Marketing start
Listing expires
Other FDA classes
Endothelin Receptor Antagonists (Mechanism)
Identifiers
Product ID 60505-4552_2950aca0-011d-ea24-bbd4-4557a0fe1aecSPL ID 2950aca0-011d-ea24-bbd4-4557a0fe1aecSPL set ID 291a782a-77e1-8a8e-e1c8-2626f305c2b7RxCUI 722116, 722122UNII HW6NV07QECUPC 0360505455232, 0360505455331
Pharmacologic class
Endothelin Receptor Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N460505455203 followed by a unit qualifier and the quantity

Package 60505-4552-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective . This label includes a boxed warning.

Indications (excerpt from the label)

Ambrisentan tablets are indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) in adult patients: To improve exercise ability and delay clinical worsening. Studies establishing effectiveness included predominantly patients with WHO Functional Class II–III symptoms and etiologies of idiopathic or heritable PAH (60%) or PAH associated with connective tissue diseases (34%). Ambrisentan tablets are an endothelin receptor antagonist indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) in adult patients: To improve exercise ability and delay clinical worsening. Studies establishing effectiveness included trials predominantly in patients wit…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 60505-4552

What is NDC 60505-4552?
60505-4552 is the product NDC for Ambrisentan, Ambrisentan 5 mg/1 tablet, film coated, listed with the FDA by Apotex Corp.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?
Ambrisentan.
What is the active ingredient?
Ambrisentan.
Who is the labeler?
Apotex Corp., NDC labeler code 60505. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Ambrisentan?
23 other product NDCs are listed under this name. See all Ambrisentan NDCs.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Ambrisentan NDCs
ProductStrengthForm · routeLabelerProduct NDCPackage NDCs (11-digit)
AmbrisentanAmbrisentan 5 mg/1Tablet, Film coatedOralQuallent Pharmaceuticals Health LLC82009-14182009-0141-30
AmbrisentanAmbrisentan 10 mg/1Tablet, Film coatedOralQuallent Pharmaceuticals Health LLC82009-14282009-0142-30
AmbrisentanAmbrisentan 10 mg/1Tablet, Film coatedOralApotex Corp.60505-455360505-4553-03
ambrisentanAmbrisentan 10 mg/1Tablet, Film coatedOralA-S Medication Solutions50090-767050090-7670-00
ambrisentanAmbrisentan 5 mg/1Tablet, Film coatedOralA-S Medication Solutions50090-767150090-7671-00
ambrisentanAmbrisentan 5 mg/1Tablet, Film coatedOralAurobindo Pharma Limited59651-49459651-0494-30
ambrisentanAmbrisentan 10 mg/1Tablet, Film coatedOralAurobindo Pharma Limited59651-49559651-0495-30
AmbrisentanAmbrisentan 5 mg/1Tablet, Film coatedOralGolden State Medical Supply, Inc.51407-59451407-0594-30
AmbrisentanAmbrisentan 10 mg/1Tablet, Film coatedOralGolden State Medical Supply, Inc.51407-59551407-0595-30
AmbrisentanAmbrisentan 5 mg/1Tablet, Film coatedOralActavis Pharma, Inc.0591-240500591-2405-30

All 24 Ambrisentan NDCs

Other NDCs under ANDA 210701

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 210701
ProductStrengthForm · routeLabelerProduct NDC
AmbrisentanAmbrisentan 5 mg/1Tablet, Film coatedOralGolden State Medical Supply, Inc.51407-594
AmbrisentanAmbrisentan 10 mg/1Tablet, Film coatedOralGolden State Medical Supply, Inc.51407-595
AmbrisentanAmbrisentan 10 mg/1Tablet, Film coatedOralApotex Corp.60505-4553

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in